Institut de Cancérologie Strasbourg
In research, Institut de Cancérologie Strasbourg stands highest in Medicine (#6,068 of 10,443 worldwide) and Health Sciences (#7,663 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Oncology and Pulmonary and Respiratory Medicine — Oncology is 12.8× its share of world research.
- World rank, 2022–2025
- #15,482 of 28,054 · #26,285 all time
- Rank in France
- #658 of 1,422
- Research works
- 285 ▲ 2656% vs 2013–17
- Citations
- 3.3k 11.7 per fractional work
- Top-10% rate
- 12.7% record average 16.5%
- Open access
- 50% world 28%
What is Institut de Cancérologie Strasbourg known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| MedicineField | #6,068 of 10,443 | 12.3% | 120 | #11011 | |
| Health SciencesDomain | #7,663 of 11,982 | 12.4% | 123 | #13864 |
Each strip is that field’s whole ranked pool, with the notch where Institut de Cancérologie Strasbourg sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
What does Institut de Cancérologie Strasbourg specialise in?
Where its research is concentrated relative to its size: Oncology takes 12.8× the share of its output that it takes of world research.
- OncologySubfield · 23.4 works13×
- Pulmonary and Respiratory MedicineSubfield · 26.1 works10×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.9×. Every wedge is a field page.
- Medicine 3.9×
- Biochemistry, Genetics and Molecular Biology 2.5×
- Veterinary 1.6×
- Immunology and Microbiology 1.2×
- Physics and Astronomy 1.0×
- Health Professions 0.6×
- Economics, Econometrics and Finance 0.5×
- Mathematics 0.5×
- Neuroscience 0.4×
- Pharmacology, Toxicology and Pharmaceutics 0.4×
- Dentistry 0.2×
- Chemistry 0.2×
- Materials Science 0.1×
- Energy 0.1×
- Nursing 0.1×
- Decision Sciences 0.1×
- Engineering 0.1×
- Psychology 0.1×
- Computer Science 0.1×
- Social Sciences 0.1×
- Environmental Science 0.0×
- Business, Management and Accounting 0.0×
- Agricultural and Biological Sciences 0.0×
- Earth and Planetary Sciences 0.0×
Who are the top researchers at Institut de Cancérologie Strasbourg?
Ranked on the composite score, Philippe Barthélémy, S. Guihard and Philippe Baltzinger lead among researchers whose main affiliation is Institut de Cancérologie Strasbourg.
- 1 Philippe Barthélémy France · #812,442 worldwide 57 citations · 27 works
- 2 S. Guihard France · #953,086 worldwide 12 citations · 17 works
- 3 Philippe Baltzinger France · #1,340,637 worldwide 3 citations · 17 works
- 4 Carole Mathelin France · #1,358,668 worldwide 12 citations · 32 works
- 5 Justine Gantzer France · #1,435,677 worldwide 4 citations · 17 works
Which keywords describe research at Institut de Cancérologie Strasbourg?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Chemotherapy, Radiotherapy, Prognostic Factors, Genetic Mutations, Targeted Therapy, Clinical Trials and Neoadjuvant Therapy.
- Cognitive Function
- PD-1 and PD-L1
- Radiosurgery
- Treatment Response
- Breast Tumours
- Temozolomide
- Renal Cell Carcinoma
- Nephron-Sparing Surgery
- Clinical Guidelines
- Therapy
- Molecular Subtypes
- Metastasis
- Molecular Classification
- Survival Analysis
- Biomarkers
- Tumor Microenvironment
- Neoadjuvant Therapy
- Targeted Therapy
- Prognostic Factors
- Chemotherapy
- Immunotherapy
- Radiotherapy
- Genetic Mutations
- Clinical Trials
- Molecular Characterization
- Clinical Practice Guidelines
- Treatment
- Cancer
- Breast Cancer
- Metastatic
- Gene Expression
- Genomic Profiling
- Dosimetry
- Prognostic Markers
- Glioblastoma
- Surgical Management
- Precision Medicine
- Metastatic Breast Cancer
- Immune Checkpoint Blockade
- PET Imaging
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Immunotherapy27▲ 24×17 topics
- Chemotherapy21▲ 19×23 topics
- Radiotherapy16▲ 25×12 topics
- Prognostic Factors15▲ 21×14 topics
- Genetic Mutations13▲ 19×14 topics
- Targeted Therapy11▲ 31×5 topics
- Clinical Trials11▲ 9.9×9 topics
- Neoadjuvant Therapy10▲ 27×5 topics
- Molecular Characterization10▲ 34×5 topics
- Tumor Microenvironment9▲ 13×8 topics
- Clinical Practice Guidelines9▲ 10×10 topics
- Biomarkers8▲ 7.5×10 topics
- Treatment8▲ 4.1×21 topics
- Survival Analysis8▲ 18×6 topics
- Cancer8▲ 3.5×31 topics
- Molecular Classification7▲ 30×4 topics
- Breast Cancer7▲ 19×10 topics
- Metastasis7▲ 13×10 topics
- Metastatic7▲ 67×2 topics
- Molecular Subtypes7▲ 50×3 topics
- Gene Expression6▲ 6.6×10 topics
- Therapy6▲ 20×5 topics
- Genomic Profiling6▲ 36×2 topics
- Clinical Guidelines6▲ 13×4 topics
- Dosimetry6▲ 51×2 topics
- Nephron-Sparing Surgery5▲ 95×1 topic
- Prognostic Markers5▲ 30×3 topics
- Renal Cell Carcinoma5▲ 95×1 topic
- Glioblastoma5▲ 45×1 topic
- Temozolomide5▲ 45×1 topic
- Surgical Management5▲ 7.2×10 topics
- Breast Tumours5▲ 61×1 topic
- Precision Medicine5▲ 6.1×6 topics
- Treatment Response5▲ 61×1 topic
- Metastatic Breast Cancer4▲ 49×2 topics
- Radiosurgery4▲ 30×3 topics
- Immune Checkpoint Blockade4▲ 25×1 topic
- PD-1 and PD-L14▲ 25×1 topic
- PET Imaging4▲ 16×4 topics
- Cognitive Function4▲ 14×4 topics
Which research topics does Institut de Cancérologie Strasbourg publish most on?
By volume in 2022–2025: Renal cell carcinoma treatment, Glioma Diagnosis and Treatment, Breast Cancer Treatment Studies and Cancer Immunotherapy and Biomarkers.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Renal cell carcinoma treatment Pulmonary and Respiratory Medicine 5 works
- 2 Glioma Diagnosis and Treatment Genetics 5 works
- 3 Breast Cancer Treatment Studies Cancer Research 5 works
- 4 Cancer Immunotherapy and Biomarkers Oncology 4 works
- 5 Advanced Radiotherapy Techniques Radiation 3 works
- 6 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 3 works
- 7 Brain Metastases and Treatment Pulmonary and Respiratory Medicine 3 works
- 8 Bladder and Urothelial Cancer Treatments Surgery 3 works
- 9 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 3 works
- 10 Cancer Genomics and Diagnostics Cancer Research 3 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Institut de Cancérologie Strasbourg's research output changed?
Output in 2018–2022 was 2656% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Strasbourg
- Université de Strasbourg
- Hôpitaux Universitaires de Strasbourg
- Hôpital Civil, Strasbourg
- Institut de Physique et Chimie des Matériaux de Strasbourg
- Hôpital d'Hautepierre
- Institut de Biologie Moléculaire et Cellulaire
- Institut de Virologie
- Institut Charles Sadron
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.